凯姆菲罗尔的抗癌潜力:基于体外研究的系统审查
Everton Freitas de Morais1, Lilianny Querino Rocha de Oliveira1, Hannah Gil de Farias Morais2
1Graduate Program in Oral Biology, Department of Oral Diagnosis, School of Dentistry, University of Campinas, Piracicaba 13414-018, SP, Brazil.
Cancers
|February 10, 2024
概括
凯姆菲罗尔 (KMP) 是一种天然的黄类化合物,通过抑制瘤生长,增殖和血管生成,显示出显著的抗癌特性. 它还增强了化疗的敏感性,为固体瘤提供了有前途的治疗选择.
科学领域:
- 在瘤学瘤学.
- 自然产品 化学 化学
- 分子生物学分子生物学
背景情况:
- 由于瘤异质性,癌症治疗面临着挑战.
- 天然产品,特别是黄类,在癌症预防和治疗方面表现有前途.
- 凯姆费醇 (KMP) 是一种具有已知的抗炎,抗氧化和抗癌特性的生物活性黄类化合物.
研究的目的:
- 系统地审查凯姆菲罗尔 (KMP) 对各种固体恶性瘤的治疗潜力.
- 巩固关于KMP在癌症中的作用机制的证据.
- 评估KMP在组合疗法中的作用.
主要方法:
- 在多个数据库 (EMBASE,PubMed,Scopus等) 中按照PRISMA指南进行系统的文献搜索. ) 的情况.
- 包括64项基于预先定义的选择标准的研究.
- 对KMP对癌细胞行为和分子标志物影响的体外数据的分析.
主要成果:
- 在体外研究表明,KMP控制瘤细胞周期,增殖,亡,迁移和入侵.
- 凯姆菲罗尔抑制血管新生和表皮细胞-介质细胞过渡的关键标志物.
- KMP增强了癌细胞对化学疗法药物的敏感性,如西斯普拉丁和5-甲.
结论:
- 凯姆费醇 (KMP) 通过多个分子途径表现出显著的抗瘤作用.
- KMP是固体瘤的一种有前途的治疗化合物.
- 将KMP与现有的抗癌药物结合使用可能会提高治疗疗效和可预测性.
相关概念视频
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Cancer Prevention
6.5K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.5K
Cancer Therapies
8.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.6K
Targeted Cancer Therapies
7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.1K


